4//SEC Filing
HEALTH NET INC 4
Accession 0001179110-14-014484
CIK 0000916085operating
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 7:56 PM ET
Size
23.6 KB
Accession
0001179110-14-014484
Insider Transaction Report
Form 4
MAYHEW KARIN D
SVPOrganization Effectiveness
Transactions
- Sale
Common Stock
2014-09-22$46.80/sh−10,000$468,000→ 53,361 total - Exercise/Conversion
Common Stock
2014-09-23$32.59/sh+42,890$1,397,785→ 96,251 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-09-22−18,000→ 0 totalExercise: $30.73Exp: 2018-02-18→ Common Stock (18,000 underlying) - Exercise/Conversion
Common Stock
2014-09-22$32.59/sh+10,921$355,915→ 64,282 total - Exercise/Conversion
Common Stock
2014-09-22$30.73/sh+18,000$553,140→ 71,361 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-09-23−42,890→ 6,189 totalExercise: $32.59Exp: 2015-05-13→ Common Stock (42,890 underlying) - Sale
Common Stock
2014-09-22$46.41/sh−10,921$506,844→ 53,361 total - Sale
Common Stock
2014-09-22$46.54/sh−18,000$837,720→ 53,361 total - Sale
Common Stock
2014-09-23$46.07/sh−42,890$1,975,942→ 53,361 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-09-22−10,921→ 49,079 totalExercise: $32.59Exp: 2015-05-13→ Common Stock (10,921 underlying)
Footnotes (9)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.57 to $47.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Act").
- [F2]Includes shares held by the Karin Mayhew 2006 Revocable Trust, of which the Reporting Person is a trustee and beneficiary.
- [F3]Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 13, 2005 under the Issuer's 2005 Long-Term Incentive Plan, as amended (the "2005 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2005 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.37 to $46.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- [F5]Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on February 18, 2011 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2011 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2011 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- [F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.40 to $46.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- [F7]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.77 to $46.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- [F8]The 2005 Grant became exercisable in 25% increments on each of the first, second, third and fourth anniversaries of May 13, 2005, the grant date.
- [F9]The 2011 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of February 18, 2011, the grant date.
Documents
Issuer
HEALTH NET INC
CIK 0000916085
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000916085
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 7:56 PM ET
- Size
- 23.6 KB